Antineuronal antibodies in migraine patients with white matter lesions

Recai Türkoğlu1, Erdem Tüzün, Sema Içöz

  • 1Department of Neurology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.

Insights

Migraine patients with white matter lesions show a higher frequency of antineuronal antibodies. This suggests inflammation may play a role in migraine pathogenesis, differentiating them from healthy individuals.

Area of Science:

  • Neurology
  • Immunology
  • Neuroimaging

Background:

  • Focal hyperintense white matter lesions are occasionally observed in migraine patients via Magnetic Resonance Imaging (MRI).
  • The immunological factors associated with these white matter lesions (WML) in migraine remain undefined.
  • Understanding the link between WML and immune responses is crucial for migraine research.

Purpose of the Study:

  • To investigate the association between white matter lesions (WML) in migraine patients and the presence of antineuronal antibodies.
  • To determine if antineuronal antibodies are specific to migraine patients with WML compared to those without, multiple sclerosis patients, and healthy controls.
  • To explore the potential role of inflammation in migraine pathogenesis.

Main Methods:

  • Sera from 17 migraine patients with WML, 19 migraine patients without WML, 20 multiple sclerosis patients with WML, and 20 healthy controls were analyzed.
  • Indirect immunohistochemistry was employed to detect immunoglobulin G (IgG) antibodies reacting with rat brain tissue.
  • Demographic, clinical features, and systemic autoantibody frequencies were compared across groups.

Main Results:

  • Migraine patients with WML showed a significantly higher frequency of antineuronal antibodies (12/17) compared to migraine patients without WML (2/19).
  • The antineuronal antibodies in migraine patients predominantly targeted neuronal cytoplasm and the cerebellar molecular layer.
  • No antineuronal antibodies were detected in multiple sclerosis patients or healthy controls.

Conclusions:

  • The presence of antineuronal antibodies in migraine patients with WML suggests an autoimmune or inflammatory component in their condition.
  • These findings imply that inflammation may be involved in the pathogenesis of migraine, particularly in cases with associated white matter lesions.
  • Antineuronal antibodies could serve as a potential biomarker for a subset of migraine patients.